Skip to main content
. Author manuscript; available in PMC: 2017 Jun 26.
Published in final edited form as: Am J Med. 2013 Apr 15;126(6):541.e1–541.e14. doi: 10.1016/j.amjmed.2012.11.030

Table 2.

Groupings of variables (Block) used in models

Block Variables
1 Epogen (EPO) dose during exposure period
2 Block 1 & age, sex, race
3 Block 2 & baseline hemoglobin, ferritin, and index TSAT
4 (Fully adjusted model) Block 3 & pneumonia, vascular access infection, or sepsis in past 6 months; any infection in past month; most recent vascular access is catheter; vintage; baseline albumin; baseline EPO dose; baseline iron dose; history of diabetes, stroke, myocardial infarction, chronic obstructive pulmonary disease, cancer, or gasterointestinal bleeding in past 6 months; number of hospital days in past month, and body mass index
5 (Sensitivity analysis) Block 4 & reason for ESRD (Diabetes,glomerulonephritis, hypertension, other); history of the following in the past 6 months: heart problems (combining ischemic heart disease, other heart, peripheral vascular disease, coronary artery bypass grafting/coronary artery stenting/percutaneous coronary angioplasty), hypertension, rheumatic heart disease, psychiatric problems, transfusion, autoimmune disorder, blood loss anemia, pulmonary circulation disease, ulcer, liver disease, other neurological problem, substance use.; year; geographic region; Medicaid eligibility